In this framework, the skin is no longer a surface to be fixed but a system to be optimised. From microbiome to mitochondria, ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...